BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23764768)

  • 1. Global and gene-specific promoter methylation analysis in primary hyperparathyroidism.
    Sulaiman L; Juhlin CC; Nilsson IL; Fotouhi O; Larsson C; Hashemi J
    Epigenetics; 2013 Jun; 8(6):646-55. PubMed ID: 23764768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours.
    Juhlin CC; Kiss NB; Villablanca A; Haglund F; Nordenström J; Höög A; Larsson C
    PLoS One; 2010 Mar; 5(3):e9472. PubMed ID: 20208994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of parathyroid tumors from two patients with hereditary colorectal cancer syndromes.
    Andreasson A; Sulaiman L; do Vale S; Martins JM; Ferreira F; Miltenberger-Miltenyi G; Batista L; Haglund F; Björck E; Nilsson IL; Höög A; Larsson C; Juhlin CC
    Fam Cancer; 2012 Sep; 11(3):355-62. PubMed ID: 22395475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation status of the CpG islands in vitamin D and calcium-sensing receptor gene promoters does not explain the reduced gene expressions in parathyroid adenomas.
    Varshney S; Bhadada SK; Sachdeva N; Arya AK; Saikia UN; Behera A; Rao SD
    J Clin Endocrinol Metab; 2013 Oct; 98(10):E1631-5. PubMed ID: 23913941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced Calcium Sensing Receptor (CaSR) Expression Is Epigenetically Deregulated in Parathyroid Adenomas.
    Singh P; Bhadada SK; Dahiya D; Arya AK; Saikia UN; Sachdeva N; Kaur J; Brandi ML; Rao SD
    J Clin Endocrinol Metab; 2020 Sep; 105(9):3015-24. PubMed ID: 32609827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas.
    Arya AK; Bhadada SK; Singh P; Sachdeva N; Saikia UN; Dahiya D; Behera A; Bhansali A; Rao SD
    Sci Rep; 2017 Jun; 7(1):3123. PubMed ID: 28600574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics and epigenetics of nonfamilial (sporadic) parathyroid tumours.
    Westin G
    J Intern Med; 2016 Dec; 280(6):551-558. PubMed ID: 27071708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide and locus specific alterations in CDC73/HRPT2-mutated parathyroid tumors.
    Sulaiman L; Haglund F; Hashemi J; Obara T; Nordenström J; Larsson C; Juhlin CC
    PLoS One; 2012; 7(9):e46325. PubMed ID: 23029479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors.
    Hahn MA; Howell VM; Gill AJ; Clarkson A; Weaire-Buchanan G; Robinson BG; Delbridge L; Gimm O; Schmitt WD; Teh BT; Marsh DJ
    Endocr Relat Cancer; 2010 Mar; 17(1):273-82. PubMed ID: 20026646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant Epigenetic Alteration of PAX1 Expression Contributes to Parathyroid Tumorigenesis.
    Singh P; Bhadada SK; Arya AK; Saikia UN; Sachdeva N; Dahiya D; Kaur J; Brandi ML; Rao SD
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e783-e792. PubMed ID: 34453169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GCM2 Silencing in Parathyroid Adenoma Is Associated With Promoter Hypermethylation and Gain of Methylation on Histone 3.
    Singh P; Bhadada SK; Dahiya D; Saikia UN; Arya AK; Sachdeva N; Kaur J; Behera A; Brandi ML; Rao SD
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e4084-e4096. PubMed ID: 34077544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification.
    Svedlund J; Koskinen Edblom S; Marquez VE; Åkerström G; Björklund P; Westin G
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1307-15. PubMed ID: 22544915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DNA methylome of benign and malignant parathyroid tumors.
    Starker LF; Svedlund J; Udelsman R; Dralle H; Akerström G; Westin G; Lifton RP; Björklund P; Carling T
    Genes Chromosomes Cancer; 2011 Sep; 50(9):735-45. PubMed ID: 21638518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant DNA methylation of WNT pathway genes in the development and progression of CIMP-negative colorectal cancer.
    Galamb O; Kalmár A; Péterfia B; Csabai I; Bodor A; Ribli D; Krenács T; Patai ÁV; Wichmann B; Barták BK; Tóth K; Valcz G; Spisák S; Tulassay Z; Molnár B
    Epigenetics; 2016 Aug; 11(8):588-602. PubMed ID: 27245242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
    Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of RASSF1A tumor suppressor gene by aberrant promoter hypermethylation in human pituitary adenomas.
    Qian ZR; Sano T; Yoshimoto K; Yamada S; Ishizuka A; Mizusawa N; Horiguchi H; Hirokawa M; Asa SL
    Lab Invest; 2005 Apr; 85(4):464-73. PubMed ID: 15711568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of two promoters for the human calcium-sensing receptor (CaSR) and changes of CaSR expression in parathyroid adenomas.
    Chikatsu N; Fukumoto S; Takeuchi Y; Suzawa M; Obara T; Matsumoto T; Fujita T
    J Biol Chem; 2000 Mar; 275(11):7553-7. PubMed ID: 10713061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
    Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
    World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic alterations in human parathyroid tumors.
    Verdelli C; Forno I; Vaira V; Corbetta S
    Endocrine; 2015 Jun; 49(2):324-32. PubMed ID: 25722013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.